These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7368169)

  • 1. Effect of protamine on heparin antithrombin III complexes. In vivo studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):375-82. PubMed ID: 7368169
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):367-74. PubMed ID: 7368168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of platelet factor 4 on the neutralization of heparin by protamine.
    Shanberge JN; Quattrociocchi-Longe TM
    Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protamine sulfate on antithrombin III activity.
    Matsuo T; Shanberge JN; Matsuo O
    Clin Chim Acta; 1983 Jul; 131(3):233-8. PubMed ID: 6883717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.
    Soulier JP; Gozin D; Lerable J
    Thromb Res; 1984 May; 34(3):255-62. PubMed ID: 6729779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.
    Hashimoto K; Yamagishi M; Sasaki T; Nakano M; Kurosawa H
    Ann Thorac Surg; 1994 Sep; 58(3):799-804; discussion 804-5. PubMed ID: 7944706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
    Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparin.
    Falkon L; Garí M; Gich I; Fontcuberta J
    Thromb Res; 1998 Jan; 89(2):79-83. PubMed ID: 9630311
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
    DeLucia A; Wakefield TW; Andrews PC; Nichol BJ; Kadell AM; Wrobleski SK; Downing LJ; Stanley JC
    J Vasc Surg; 1993 Jul; 18(1):49-58; discussion 58-60. PubMed ID: 8326659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest.
    Godal HC; Gjengedal G
    Scand J Haematol; 1971; 8(3):194-9. PubMed ID: 5093996
    [No Abstract]   [Full Text] [Related]  

  • 14. Lethal effect of protamine and histone on competent Bacillus subtilis cells. Inhibition of genetic transformation by protamine in sublethal concentration.
    Antohi S; Popescu A
    Mol Gen Genet; 1979 Mar; 170(3):345-9. PubMed ID: 111002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protamine filter for extracorporeal heparin removal. Development, testing, blood compatibility evaluation, and future direction.
    Byun Y; Yun JH; Han IS; Fu Y; Shanberge JN; Yang VC
    ASAIO J; 1995; 41(3):M301-5. PubMed ID: 8573812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of heparin effects by protamine sulfate].
    GERENDAS M
    Orv Hetil; 1956 Jan; 97(5):113-8. PubMed ID: 13335127
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y; Kanayama S; Maeda Y; Urano S; Kitani T; Watada M; Nakagawa M; Ijichi H
    Thromb Res; 1981 Oct 1-15; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy-associated plasma protein-A (PAPP-A) inhibits thrombin-induced coagulation of plasma.
    Bischof P; Meisser A; Haenggeli L; Reber G; Bouvier C; Béguin F; Herrmann WL; Sizonenko PC
    Thromb Res; 1983 Oct; 32(1):45-55. PubMed ID: 6197764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.
    Harenberg J; Würzner B; Zimmermann R; Schettler G
    Thromb Res; 1986 Nov; 44(4):549-54. PubMed ID: 3798415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.